Candace Malone, NP
Family · Spartanburg, SCNPI 1023550894
Payments from drug & device makers
Across 320 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$925
- AstraZeneca$762
- Pfizer$520
- Lilly USA, LLC$452
- Dexcom, Inc.$408
- Novo Nordisk$312
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,720100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $925 |
| AstraZeneca | 36 | $762 |
| Pfizer | 36 | $520 |
| Lilly USA, LLC | 20 | $452 |
| Dexcom, Inc. | 20 | $408 |
| Novo Nordisk | 24 | $312 |
| GSK | 16 | $277 |
| Intuity Medical Inc | 9 | $262 |
| Amgen | 15 | $229 |
| Bayer | 10 | $167 |
| Novartis | 9 | $165 |
| Astellas Pharma US Inc | 6 | $124 |
| Boehringer Ingelheim | 6 | $118 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Eisai Inc. | 4 | $102 |
| Johnson & Johnson | 5 | $92 |
| Ascensia Diabetes Care US Inc. | 4 | $79 |
| Merck | 3 | $72 |
| Exact Sciences | 4 | $63 |
| Esperion Therapeutics, Inc. | 3 | $50 |
| Biohaven Pharmaceuticals, Inc. | 2 | $46 |
| Hikma Pharmaceuticals USA | 3 | $46 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Verona Pharma, Inc. | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $22 |
| Inari Medical, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Radius Health, Inc. | 1 | $19 |
| Halozyme Inc | 1 | $13 |
| Dynavax Technologies Corporation | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$5,720 in reported general payments places this provider in the 90th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 25 | $31,162 |
| FarxigaDapagliflozin Propanediol | 26 | $24,584 |
| TrulicityDulaglutide | 22 | $20,937 |
| XareltoRivaroxaban | 17 | $18,747 |
| EliquisApixaban | 21 | $17,389 |
| MyrbetriqMirabegron | 16 | $14,337 |
| RybelsusSemaglutide | 12 | $14,099 |
| MounjaroTirzepatide | 13 | $12,068 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,616 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $5,532 |
| Atorvastatin Calcium | 351 | $3,995 |
| Bupropion XlBupropion Hcl | 44 | $2,118 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 67 | $1,870 |
| Gabapentin | 122 | $1,739 |
| Levothyroxine Sodium | 146 | $1,722 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $452 | $33,00535 claims |
| Boehringer IngelheimJardiance | $118 | $31,16225 claims |
| AstraZenecaFarxiga, Symbicort | $762 | $30,11649 claims |
| Johnson & JohnsonXarelto | $92 | $18,74717 claims |
| PfizerEliquis | $520 | $17,38921 claims |
| Astellas Pharma US IncMyrbetriq | $124 | $14,33716 claims |
| Novo NordiskRybelsus | $312 | $14,09912 claims |
| GSKBreo Ellipta | $277 | $5,61612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,248 family providers in South Carolina.
Other family in Spartanburg
- Ashley McKinneySpartanburg$16K
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.